Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.
about
Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacityMHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cellsSLE-associated risk factors affect DC functionTargeting allergen to Fc gammaRI: a strategy to treat allergic disease?The importance of human FcgammaRI in mediating protection to malaria.Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal StudiesFc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cellsCD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.IgG subclasses and allotypes: from structure to effector functions.Immune complex-mediated antigen presentation induces tumor immunity.Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment.Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.Mouse model recapitulating human Fcγ receptor structural and functional diversityThe potential of exosomes in immunotherapy.Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.Neutrophils in antibody-based immunotherapy of cancer.A vault nanoparticle vaccine induces protective mucosal immunity.Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopesProstaglandin E2 modulates dendritic cell function during chlamydial genital infection.Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.The function of Fcγ receptors in dendritic cells and macrophages.Mouse and human FcR effector functions.C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake.Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.FcγRI (CD64): an identity card for intestinal macrophages.Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis.Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen.Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.Modulation of FcgammaRI (CD64) ligand binding by blocking peptides of periplakin.FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes.Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties.The pathophysiology of anaphylaxis.Fc receptors as targets for immunotherapy.Structural bases of Fc gamma R functions.Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions.CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.Activating and inhibitory Fcγ receptors in immunotherapy: being the actor or being the target
P2860
Q24564238-AB1AD29D-A81F-46AB-ACE9-E29764F6E427Q24643634-DE49A2D0-2333-4B40-953E-1CDD5325D06FQ26774797-EB06DE3B-3940-4B0E-84CF-827754CE1B49Q30437725-C6CB1729-CFDD-431F-B91C-75BDBCCD41A5Q33285037-96093172-8BA4-4C1F-BC78-4F7A3565B8BDQ33686907-E00DF12C-EF33-426E-8F60-5224B7A926D1Q34087802-A9BD5185-3332-4BBC-B01A-22B9D957DCE3Q34177368-45A133E8-9CEB-4F96-8558-3E96647B5F6EQ34368678-043104E6-315B-429D-B04D-9F3AB80F09E3Q34793164-14C3739D-737E-4A17-AB30-8FE063CF27B6Q35788046-640C7338-5C70-4100-974A-6FD6D113EE59Q35805480-2A2836E9-A7CB-44ED-98C0-2A19C4CA3D7DQ35924857-60537F79-D42F-4377-AD24-89B7BACC8FB9Q36161201-664A365B-A8A4-44DD-9E23-C96F2BDBA074Q36934308-EE0BD9A6-7724-421D-A326-C1CE34575AE2Q37032641-CE49C26C-C139-4DED-B8E1-8B0F3C11DED2Q37165790-506076A1-242C-4EC2-BB83-6F0C48C0D632Q37209029-8F5795BC-A528-4FED-BDE8-879D14441588Q37256661-47015237-C8D1-4246-A865-AB5032C8A362Q37360991-8EB3879C-5B0B-4DED-88E8-A8AD2B37BEE5Q37859271-55D16511-FC1A-4D57-92E0-FA5A12BC9FDEQ38162231-04CADC52-453E-42E4-81E1-CA4F942AA3F9Q38180345-72205535-076A-43BE-A81D-A2206876F974Q38615349-733066E7-695A-4CAA-95F1-A344CCD94D2BQ38912827-B8C15CCA-C23A-4908-A449-F2D65F1A328CQ40300686-32B91FD3-01B4-43EB-B9A2-6BB820CA3778Q40330620-53C4AB5A-7FA2-4E8A-807B-9639853AAB1CQ40381598-0F78FFF7-F3F2-4BA3-B7EB-64C3149B3EA0Q41837360-293CA7F7-AF02-4D84-89FF-A4EA45B0704BQ42096393-ABD9966F-9BBD-48A8-93B3-F626B42C2527Q43048724-D002E640-6A47-4260-93EC-D954E98BEFE9Q44909714-FC394C08-A821-4DE8-8003-F019D4E5B06EQ45832383-0123B3F9-6E97-4E61-BFAC-89CEFABF3A2CQ47265866-4A5BE95E-106C-43F4-81A8-FEB2EA15937EQ47810222-14557F5F-5204-4C82-823D-CBBB0F071C02Q47889742-D9A1E43E-356C-4603-9390-1B005D1E0B79Q47889812-77974881-540D-4421-9A9A-C49B755A4A20Q47944221-E94BCDDA-E433-4174-B34C-A77D5B1B844DQ53076778-C4FE67FD-3135-4050-A1CD-FA88F64AC0A7Q57583344-9018EC2B-0930-4CEB-B20B-84E9299E7F39
P2860
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@en
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@nl
type
label
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@en
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@nl
prefLabel
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@en
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@nl
P2093
P2860
P356
P1476
Antigen targeting to myeloid-s ...... responses in transgenic mice.
@en
P2093
F M Hofhuis
I A Heijnen
J G van de Winkel
J S Verbeek
M J van Vugt
N A Fanger
R F Graziano
T P de Wit
P2860
P304
P356
10.1172/JCI118420
P407
P577
1996-01-01T00:00:00Z